Enterprise Value
1.665B
Cash
403.7M
Avg Qtr Burn
-24.93M
Short % of Float
16.60%
Insider Ownership
7.95%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Atacicept Details Lupus nephritis | Phase 3 Update | |
Atacicept Details IgA nephropathy | Phase 2b Data readout | |
MAU868 Details Kidney transplantation, BK virus | Phase 2b Update |